March 15, 2020 01:03 PM EDTUpdated March 16, 06:14 AM
R&D
Coronavirus

Trump ad­min­is­tra­tion tries to lure Ger­man coro­n­avirus vac­cine mak­er to US — re­ports

Jason Mast

Editor

The Trump ad­min­is­tra­tion is try­ing to lure Cure­Vac, one of the first com­pa­nies to en­ter the hunt for a coro­n­avirus vac­cine, away from its base …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times